It has been reported that UC-MSC can inhibit TGF-β1 expression in the kidney tissue of the diabetic nephropathy mice model and inhibit its downstream PI3K/Akt and MAPK signaling pathways (Li et al., 2020). The gene discussed is AKT1; the disease is diabetic kidney disease.